Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 29, 2015

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
Asthma
Interventions
BIOLOGICAL

Tralokinumab

Subcutaneous Injection

OTHER

Placebo

Subcutaneous Injection

Trial Locations (15)

2400

Research Site, København NV

2650

Research Site, Hvidovre

5000

Research Site, Odense C

8000

Research Site, Århus C

9000

Research Site, Aalborg

V5Z 1M9

Research Site, Vancouver

H4A 3J1

Research Site, Montreal

G1V 4G5

Research Site, Québec

BT12 6BA

Research Site, Belfast

G12 OYN

Research Site, Glasgow

LE3 9QP

Research Site, Leicester

Unknown

Research Site, London

M23 9QZ

Research Site, Manchester

NG5 1PB

Research Site, Nottingham

SO16 6YD

Research Site, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY